Stellar Biotechnologies, Inc. (SBOT) Reaches $0.85 1 Year Low; 1 Analysts Covering Intrepid Potash, Inc. (IPI)

December 22, 2017 - By Winifred Garcia

The stock of Stellar Biotechnologies, Inc. (NASDAQ:SBOT) hit a new 52-week low and has $0.79 target or 7.00% below today’s $0.85 share price. The 7 months bearish chart indicates high risk for the $8.94M company. The 1-year low was reported on Dec, 22 by Barchart.com. If the $0.79 price target is reached, the company will be worth $625,940 less. The stock increased 2.39% or $0.0198 during the last trading session, reaching $0.85. About 33,032 shares traded. Stellar Biotechnologies, Inc. (NASDAQ:SBOT) has declined 60.19% since December 22, 2016 and is downtrending. It has underperformed by 76.89% the S&P500.

Among 10 analysts covering Intrepid Potash Inc. (NYSE:IPI), 1 have Buy rating, 3 Sell and 6 Hold. Therefore 10% are positive. Intrepid Potash Inc. had 25 analyst reports since July 22, 2015 according to SRatingsIntel. Credit Agricole downgraded the shares of IPI in report on Wednesday, October 28 to “Underperform” rating. Susquehanna maintained Intrepid Potash, Inc. (NYSE:IPI) on Tuesday, January 26 with “Neutral” rating. The rating was upgraded by CLSA on Tuesday, May 10 to “Outperform”. Societe Generale upgraded Intrepid Potash, Inc. (NYSE:IPI) on Tuesday, January 19 to “Sector Perform” rating. The firm earned “Hold” rating on Thursday, July 6 by BMO Capital Markets. BMO Capital Markets maintained Intrepid Potash, Inc. (NYSE:IPI) on Friday, September 8 with “Hold” rating. Cowen & Co upgraded the stock to “Market Perform” rating in Wednesday, October 14 report. The stock has “Underperform” rating by CLSA on Wednesday, October 28. Cowen & Co maintained the stock with “Market Perform” rating in Tuesday, November 24 report. The stock of Intrepid Potash, Inc. (NYSE:IPI) earned “Market Perform” rating by BMO Capital Markets on Thursday, August 3. See Intrepid Potash, Inc. (NYSE:IPI) latest ratings:




05/12/2017 Broker: Stephens Rating: Equal-Weight Initiates Coverage On
30/11/2017 Broker: Cowen & Co Rating: Sell New Target: $3.5 Maintain
31/10/2017 Broker: BMO Capital Markets Rating: Market Perform Old Target: $3 New Target: $4 Maintain
08/09/2017 Broker: BMO Capital Markets Rating: Hold New Target: $3.0 Maintain
07/08/2017 Broker: UBS Old Rating: Neutral New Rating: Sell Downgrade
03/08/2017 Broker: BMO Capital Markets Rating: Market Perform Old Target: $2 New Target: $3 Maintain
06/07/2017 Broker: BMO Capital Markets Rating: Hold New Target: $2.0000 Maintain

Intrepid Potash, Inc. produces and sells potash and langbeinite products in the United States and internationally. The company has market cap of $529.00 million. It operates in two divisions, Potash and Trio. It currently has negative earnings. The Potash segment offers muriate of potash or potassium chloride for use as a fertilizer input in the agricultural market; as a component in drilling and fracturing fluids for gas and oil wells, as well as an input to other industrial processes in the industrial market; and as a nutrient supplement in the animal feed market.

The stock increased 0.12% or $0.005 during the last trading session, reaching $4.295. About 427,245 shares traded. Intrepid Potash, Inc. (NYSE:IPI) has risen 84.68% since December 22, 2016 and is uptrending. It has outperformed by 67.98% the S&P500.

Investors sentiment decreased to 1.21 in 2017 Q3. Its down 0.30, from 1.51 in 2017Q2. It turned negative, as 18 investors sold Intrepid Potash, Inc. shares while 25 reduced holdings. 26 funds opened positions while 26 raised stakes. 59.66 million shares or 1.34% more from 58.87 million shares in 2017Q2 were reported. Amalgamated Financial Bank reported 11,777 shares or 0% of all its holdings. Advisory Service Ltd reported 0% in Intrepid Potash, Inc. (NYSE:IPI). Sg Americas Securities Limited Liability Corp invested in 0% or 15,530 shares. Saratoga Rech Inv Mgmt stated it has 0.09% of its portfolio in Intrepid Potash, Inc. (NYSE:IPI). Pub Employees Retirement Association Of Colorado invested in 19,941 shares or 0% of the stock. Lmr Prtn Limited Liability Partnership stated it has 0.02% in Intrepid Potash, Inc. (NYSE:IPI). Messner Smith Theme Value Management Limited Ca owns 3,027 shares for 0.02% of their portfolio. Deutsche Retail Bank Ag owns 88,422 shares for 0% of their portfolio. Bridgeway Capital Mgmt reported 317,600 shares stake. Goldman Sachs Gp accumulated 0% or 49,609 shares. Fuller Thaler Asset Incorporated invested 0.07% in Intrepid Potash, Inc. (NYSE:IPI). Fairfax Financial Limited Can invested 5.94% of its portfolio in Intrepid Potash, Inc. (NYSE:IPI). Moreover, Bnp Paribas Arbitrage has 0% invested in Intrepid Potash, Inc. (NYSE:IPI). Natixis accumulated 11,702 shares. D E Shaw And Company has 133,476 shares for 0% of their portfolio.

Stellar Biotechnologies, Inc., a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin protein primarily in Europe, the United States, and Asia. The company has market cap of $8.94 million. It provides KLH, an immune-stimulating molecule used as an active pharmaceutical ingredient in various immunotherapies; and as an injectable product to assess immune response. It currently has negative earnings. The firm offers its KLH protein under the Stellar KLH brand.

Analysts await Stellar Biotechnologies, Inc. (NASDAQ:SBOT) to report earnings on February, 5. They expect $-0.14 EPS, up 6.67% or $0.01 from last year’s $-0.15 per share. After $-0.12 actual EPS reported by Stellar Biotechnologies, Inc. for the previous quarter, Wall Street now forecasts 16.67% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts